Chemotherapy-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (AvKARE)
FDA approved a supplemental application for ondansetron from AvKARE, indicating a regulatory update to this product. The approval confirms c…
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (ANDA) filed by NorthStar Rx LLC.
-
FDA approval · 2014-12-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (generic) from Fresenius Kabi USA, LLC. This action relates to the…
-
FDA approval · 2014-10-17FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)
The FDA approved a supplemental application for granisetron hydrochloride submitted by Natco Pharma Limited, updating the approved generic p…
-
FDA approval · 2014-10-10FDA Approved: AKYNZEO — Original Application (Helsinn Therapeutics (U.S.), Inc.)
FDA approved AKYNZEO (netupitant and palonosetron) through an original application (NDA205718) for the prevention of chemotherapy-induced na…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-09-18FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for granisetron hydrochloride (granisetron) by Fresenius Kabi USA, LLC to update the labeling.
-
FDA approval · 2014-09-18FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron), a formulation used to prevent chemotherapy-…
-
FDA approval · 2014-09-18FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for Palonosetron hydrochloride submitted by Cipla USA Inc. under NDA 021372. This action updates…
-
FDA approval · 2014-09-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride by Mylan Institutional LLC under an ANDA.
-
FDA approval · 2014-09-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride (Mylan Institutional LLC) under an ANDA.
-
FDA approval · 2014-09-15FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride from Mylan Institutional LLC.
-
FDA approval · 2014-09-14FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Granisetron hydrochloride (generic antiemetic) under ANDA 078…
-
FDA approval · 2014-09-08FDA Approved: ONDANSETRON — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approves the original application for ondansetron from Qilu Pharmaceutical Co., Ltd., enabling the generic product to enter the market.
-
FDA approval · 2014-08-12FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for EMEND (aprepitant) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2014-07-15FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron), the transdermal antiemetic.
-
FDA approval · 2014-02-06FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for palonosetron hydrochloride submitted by Cipla USA Inc.
-
FDA approval · 2014-01-17FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)
FDA approved a supplemental application for ondansetron tablets from Actavis Pharma, Inc., adding a generic ondansetron tablet product to th…
-
FDA approval · 2013-12-24FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron from Hospira, Inc., a generic product. The approval confirms the supplemental filing…
-
FDA approval · 2013-12-24FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
The FDA documents a supplemental application for ondansetron submitted by Hospira, Inc., indicating an FDA regulatory action on this product…
-
FDA approval · 2013-12-20FDA Approved: METOCLOPRAMIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic metoclopramide hydrochloride tablet under an original application from Heritage Pharmaceuticals (d/b/a Avet Pharmaceu…
-
FDA approval · 2013-12-19FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for ondansetron hydrochloride, a generic antiemetic used to prevent nausea and vo…
-
FDA approval · 2013-12-10FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, indicating an approved modifi…
-
FDA approval · 2013-10-07FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ondansetron submitted by Sun Pharmaceutical Industries (ANDA077557). Ondansetron is a generic an…
-
FDA approval · 2013-09-19FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under the ANDA.
-
FDA approval · 2013-09-19FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for METOCLOPRAMIDE from Teva Parenteral Medicines, Inc., for the approved generic product under ANDA…